Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in Radiographic Axial Spondyloarthritis
NCT02437162Phase 3Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2015
- Primary completion
- Mar 2017
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 3 trial of ustekinumab in ankylosing spondylitis (AS), sponsored by Janssen Pharmaceutical. Started Sep 2015; status: terminated.
02
Drugs
ustekinumab
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02437162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02437162.